Greenfield Seitz Capital Management’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.31M Sell
91,137
-3,300
-3% -$294K 2.48% 9
2026
Q1
$6.1M Sell
94,437
-777
-0.8% -$55.9K 1.84% 17
2025
Q4
$6.07M Sell
95,214
-2,357
-2% -$145K 1.99% 15
2025
Q3
$6.27M Buy
97,571
+114
+0.1% +$7.72K 2.02% 12
2025
Q2
$6.86M Sell
97,457
-1,457
-1% -$80.1K 2.42% 11
2025
Q1
$4.79M Buy
98,914
+149
+0.2% +$8.3K 1.83% 23
2024
Q4
$5.66M Buy
98,765
+1,130
+1% +$77.7K 2.16% 14
2024
Q3
$7.84M Sell
97,635
-139
-0.1% -$11.5K 2.87% 7
2024
Q2
$8.95M Sell
97,774
-1,791
-2% -$164K 3.31% 7
2024
Q1
$8.93M Sell
99,565
-3,589
-3% -$309K 3.33% 6
2023
Q4
$9.3M Buy
+103,154
New +$8.4M 3.71% 3

Other funds holding MCHP

Greenfield Seitz Capital Management's MCHP Position: Q2 2026 in Review

Greenfield Seitz Capital Management reduced its Microchip Technology (MCHP) stake by 3.5% in Q2 2026, selling an estimated $294K and leaving 91,137 shares worth $8.31M. The position accounts for 2.48% of the portfolio, ranked #9.

Greenfield Seitz Capital Management first reported a position in MCHP in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.3M in Q4 2023. 1,279 funds tracked by Wall St. Rank hold MCHP as of Q2 2026.

  • Greenfield Seitz Capital Management held 91,137 shares of Microchip Technology worth $8.31M as of Q2 2026.
  • Greenfield Seitz Capital Management sold 3,300 Microchip Technology shares in Q2 2026, an estimated $294K.
  • Microchip Technology made up 2.48% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #9 holding.
  • Greenfield Seitz Capital Management first reported a position in Microchip Technology in Q4 2023 and has held it in 11 quarters since.
  • Greenfield Seitz Capital Management's Microchip Technology position peaked at $9.3M in Q4 2023.
  • 1,279 funds tracked by Wall St. Rank held Microchip Technology as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.